These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28195223)

  • 1. Celastrol, an active constituent of the TCM plant Tripterygium wilfordii Hook.f., inhibits prostate cancer bone metastasis.
    Kuchta K; Xiang Y; Huang S; Tang Y; Peng X; Wang X; Zhu Y; Li J; Xu J; Lin Z; Pan T
    Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):156-164. PubMed ID: 28195223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celastrol inhibits lipopolysaccharide-induced angiogenesis by suppressing TLR4-triggered nuclear factor-kappa B activation.
    Ni H; Zhao W; Kong X; Li H; Ouyang J
    Acta Haematol; 2014; 131(2):102-11. PubMed ID: 24157922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiangiogenic effect of celastrol on the growth of human glioma: an in vitro and in vivo study.
    Zhou YX; Huang YL
    Chin Med J (Engl); 2009 Jul; 122(14):1666-73. PubMed ID: 19719969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celastrol blocks interleukin-6 gene expression via downregulation of NF-κB in prostate carcinoma cells.
    Chiang KC; Tsui KH; Chung LC; Yeh CN; Chen WT; Chang PL; Juang HH
    PLoS One; 2014; 9(3):e93151. PubMed ID: 24664372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice.
    Yang H; Chen D; Cui QC; Yuan X; Dou QP
    Cancer Res; 2006 May; 66(9):4758-65. PubMed ID: 16651429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pristimerin Inhibits Prostate Cancer Bone Metastasis by Targeting PC-3 Stem Cell Characteristics and VEGF-Induced Vasculogenesis of BM-EPCs.
    Huang S; He P; Peng X; Li J; Xu D; Tang Y
    Cell Physiol Biochem; 2015; 37(1):253-68. PubMed ID: 26302893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celastrol Inhibits Migration and Invasion of Triple-Negative Breast Cancer Cells by Suppressing Interleukin-6 via Downregulating Nuclear Factor-κB (NF-κB).
    Yan F; Wu Z; Li Z; Liu L
    Med Sci Monit; 2020 Sep; 26():e922814. PubMed ID: 32920591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological methyl group donors block skeletal metastasis in vitro and in vivo.
    Shukeir N; Stefanska B; Parashar S; Chik F; Arakelian A; Szyf M; Rabbani SA
    Br J Pharmacol; 2015 Jun; 172(11):2769-81. PubMed ID: 25631332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory action of Celastrol on hypoxia-mediated angiogenesis and metastasis via the HIF-1α pathway.
    Huang L; Zhang Z; Zhang S; Ren J; Zhang R; Zeng H; Li Q; Wu G
    Int J Mol Med; 2011 Mar; 27(3):407-15. PubMed ID: 21249310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory action of pristimerin on hypoxia‑mediated metastasis involves stem cell characteristics and EMT in PC-3 prostate cancer cells.
    Zuo J; Guo Y; Peng X; Tang Y; Zhang X; He P; Li S; Wa Q; Li J; Huang S; Xu D
    Oncol Rep; 2015 Mar; 33(3):1388-94. PubMed ID: 25571882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SKI-606 (Bosutinib) blocks prostate cancer invasion, growth, and metastasis in vitro and in vivo through regulation of genes involved in cancer growth and skeletal metastasis.
    Rabbani SA; Valentino ML; Arakelian A; Ali S; Boschelli F
    Mol Cancer Ther; 2010 May; 9(5):1147-57. PubMed ID: 20423991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celastrol inhibits the HIF-1α pathway by inhibition of mTOR/p70S6K/eIF4E and ERK1/2 phosphorylation in human hepatoma cells.
    Ma J; Han LZ; Liang H; Mi C; Shi H; Lee JJ; Jin X
    Oncol Rep; 2014 Jul; 32(1):235-42. PubMed ID: 24859482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Implication of Paxillin in Cancer Establishment Within the Bone Environment.
    Sobkowicz AD; Sanders AJ; Mason MD; Jiang WG
    Anticancer Res; 2017 Aug; 37(8):4255-4268. PubMed ID: 28739717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells.
    Wolfram J; Suri K; Huang Y; Molinaro R; Borsoi C; Scott B; Boom K; Paolino D; Fresta M; Wang J; Ferrari M; Celia C; Shen H
    J Microencapsul; 2014; 31(5):501-7. PubMed ID: 24654943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celastrol attenuates bone erosion in collagen-Induced arthritis mice and inhibits osteoclast differentiation and function in RANKL-induced RAW264.7.
    Gan K; Xu L; Feng X; Zhang Q; Wang F; Zhang M; Tan W
    Int Immunopharmacol; 2015 Feb; 24(2):239-246. PubMed ID: 25529994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Celastrol inhibits chondrosarcoma proliferation, migration and invasion through suppression CIP2A/c-MYC signaling pathway.
    Wu J; Ding M; Mao N; Wu Y; Wang C; Yuan J; Miao X; Li J; Shi Z
    J Pharmacol Sci; 2017 May; 134(1):22-28. PubMed ID: 28522217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1.
    Zhou Y; Ji Z; Yan W; Zhou Z; Li H; Xiao Y
    Oncol Rep; 2017 Aug; 38(2):837-842. PubMed ID: 28677763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of celastrol in inhibiting metastasis of lung cancer cells by influencing Akt signaling pathway and expressing integrins].
    Xu J; Wu CL; Huang J
    Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(6):1129-33. PubMed ID: 26226758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triptolide inhibits the migration and invasion of human prostate cancer cells via Caveolin-1/CD147/MMPs pathway.
    Yuan S; Wang L; Chen X; Fan B; Yuan Q; Zhang H; Yang D; Wang S
    Biomed Pharmacother; 2016 Dec; 84():1776-1782. PubMed ID: 27847199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celastrol stimulates hypoxia-inducible factor-1 activity in tumor cells by initiating the ROS/Akt/p70S6K signaling pathway and enhancing hypoxia-inducible factor-1α protein synthesis.
    Han X; Sun S; Zhao M; Cheng X; Chen G; Lin S; Guan Y; Yu X
    PLoS One; 2014; 9(11):e112470. PubMed ID: 25383959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.